[HTML][HTML] Materials and manufacturing perspectives in engineering heart valves: a review

F Oveissi, S Naficy, A Lee, DS Winlaw, F Dehghani - Materials Today Bio, 2020 - Elsevier
Valvular heart diseases (VHD) are a major health burden, affecting millions of people
worldwide. The treatments for such diseases rely on medicine, valve repair, and artificial …

Aortic valve regurgitation: a comprehensive review

OA Akinseye, A Pathak, UN Ibebuogu - Current problems in cardiology, 2018 - Elsevier
Aortic regurgitation (AR) has an estimated prevalence of 4.9% in the Framingham study, with
moderate or severe AR occurring in 0.5% of the study population. The incidence and …

Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from …

FJ Sawaya, MA Deutsch, M Seiffert, SH Yoon… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: The aim of this study was to evaluate the use of transcatheter heart valves (THV)
for the treatment of noncalcific pure native aortic valve regurgitation (NAVR) and failing …

Expanding the indications for transcatheter aortic valve implantation

Z Rahhab, N El Faquir, D Tchetche… - Nature Reviews …, 2020 - nature.com
Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of
symptomatic severe aortic valve stenosis. Current guidelines recommend TAVI in patients at …

Transcatheter aortic valve replacement for pure native aortic valve regurgitation: the PANTHEON international project

E Poletti, O De Backer, A Scotti, G Costa… - Cardiovascular …, 2023 - jacc.org
Background Transcatheter aortic valve replacement (TAVR) in patients with pure severe
native aortic valve regurgitation (NAVR) has been associated with suboptimal results. The …

An update on new generation transcatheter aortic valves and delivery systems

G Santangelo, A Ielasi, M Pellicano, A Latib… - Journal of Clinical …, 2022 - mdpi.com
Over the last 15 years, the management of aortic valve disease has been changed by
transcatheter aortic valve replacement, which has become the standard of care across the …

[PDF][PDF] Transcatheter aortic valve implantation in 2017: state of the art

M Barbanti, JG Webb, M Gilard, D Capodanno… - 2017 - researchgate.net
In the last 15 years, transcatheter aortic valve implantation (TAVI) technology has met with
rapid uptake, with> 350,000 procedures performed in> 70 countries. Over the same period …

Aortic regurgitation

N Flint, NC Wunderlich, H Shmueli, S Ben-Zekry… - Current Cardiology …, 2019 - Springer
Abstract Purpose of Review Aortic regurgitation (AR) is a common form of valvular disease
which is characterized by reflux of blood from the aorta into the left ventricle (LV) during …

Evolving indications of transcatheter aortic valve replacement—where are we now, and where are we going

J Mesnier, V Panagides, J Nuche… - Journal of Clinical …, 2022 - mdpi.com
Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over
the last decade since the first trials including inoperable or very high risk patients. Thus …

Future of transcatheter aortic valve implantation—evolving clinical indications

R Puri, C Chamandi, T Rodriguez-Gabella… - Nature Reviews …, 2018 - nature.com
Accumulating clinical experience and technological improvements have provided the basis
for transcatheter aortic valve implantation (TAVI) to emerge as a well-established means for …